TP53 and breast neuroendocrine neoplasm: In our breast NET samples, TP53 gene pathogenetic or unknown variants were detected in 11.3% of samples, while previous breast NET studies reported the TP53 pathogenetic or unknown variants frequency to be between 0 and 7% [9, 10].